Press Releases

SAN FRANCISCO, July 25, 2023 (GLOBE NEWSWIRE) -- Adaptive Research, an organization committed to democratizing clinical trials by providing full-service support to trial investigators in community settings, is pleased to announce Kristin Andruska, MD, PhD has been appointed Senior Medical Director of Clinical Neuroscience and Scientific Research Director. Dr. Andruska will be pivotal in offering expert medical and clinical support for upcoming & ongoing trials at Adaptive Research, particularly those in movement disorders and neurodegenerative diseases."The growth of Adaptive Research is not just about expanding our team, but also about deepening our expertise," said Deepak Behera, MD, President and CEO. "With Kristin's comprehensive experience in clinical settings and in conducting clinical trials, she is ideally suited to bolster our clinical trial operations. We look forward to growing our community clinical trial network further in the coming months, which becomes more important in light of recent FDA guidelines highlighting a growing need for inclusion of clinical trial data from diverse patient populations."Kristin Andruska is a board-certified neurologist, a fellowship-trained movement disorders specialist, and a renowned expert in the field of neurodegenerative disease. Concurrent to her position at Adaptive Research, she serves as head of the California Movement Disorders Center and as an advisor for therapeutics and technologies in the neurodegenerative space. Previously, Dr. Andruska was the Medical Director of the Movement Disorders Clinic at the Parkinson’s Institute and Clinical Center, where she also led a robust clinical research program. She attended the University of Minnesota as a predoctoral fellow of the National Institute of Health’s Medical Scientist Training Program, earning both an MD and a PhD. She received a competitive Kirschstein fellowship to support her PhD research, which focused on the biochemistry of inherited neurodegenerative disease. Dr. Andruska completed her neurology residency at Washington University in Saint Louis, where she was…

SAN FRANCISCO and DALY CITY, Calif., March 07, 2023 (GLOBE NEWSWIRE) -- Adaptive Research, an integrated clinical trial site organization with a unique purpose to democratize clinical trials by integrating community physicians into the clinical trial process, and AHMC Seton Medical Center, a full-service, community based hospital offering a comprehensive range of medical specialties, today announced a collaboration to expand clinical trial access at AHMC Seton Medical Center. Seton Medical Center is recognized for its stroke treatment and cardiovascular excellence, including STEMI certification. Seton offers a comprehensive range of medical specialties on both an inpatient and outpatient basis, as well as emergency and surgical services. Seton also provides Acute Psychiatry, Wound Care, Radiation Oncology, Subacute, Skilled Nursing and Laboratory and Imaging services for the community. Through this partnership, pharmaceutical companies and clinical research organizations (CROs) may utilize Seton as a clinical trial site for investigative trials if their studies align with Seton’s patient population and the interest of patients in participating.   “Seton’s high quality medical staff and excellent reputation in the community are a welcome addition to our network of clinical trial sites,” said Deepak Behera, MD, President and Chief Executive Officer. “Because Seton treats patients with a broad array of needs from the emergency room to outpatient services, we are able to significantly expand the potential therapeutic areas available to our clients.” Sarkis Vartanian, Administrator of AHMC Seton Medical Center, added, “We are excited to partner with Adaptive Research to offer clinical trials on our campus. At Seton, we pride ourselves on innovation when it comes to patient care and this arrangement provides another unique offering for our community.” About AHMC Seton Medical Center AHMC Seton Medical Center has been serving the health care needs of San Francisco and northern San Mateo County since its founding as Mary’s Help Hospital in…

SAN FRANCISCO, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Adaptive Research, an integrated clinical trial site organization with a unique purpose to democratize clinical trials by integrating community physicians into the clinical trial process, today announced that Perminder Bhatia, M.D. has been appointed as Head of Neurology reporting to the Chief Medical Officer.  “2022 was a year of tremendous growth for Adaptive Research and with our continued expansion we are thrilled to have Perminder join our team,” said Brajesh Agrawal, M.D., Chief Medical Officer. “His extensive experience in neurology combined with his proficiency in conducting clinical trials makes him the ideal candidate to lead our neurology division. Dr. Bhatia’s appointment enhances our ability to deliver neurology trials across our network and adds to our existing scientific and medical expertise in the areas of gastroenterology and nuclear medicine. As we look ahead to this year, we expect to add expertise in other therapeutic areas including oncology, as well as expand our footprint into multiple geographical areas.” Dr. Perminder Bhatia is a board-certified Neurologist, Principal Investigator for Clinical Trials and Director at the Neuropain Medical Center in Fresno, CA, which he founded in 2003. He is also on staff at Community Health System, Fresno and the Saint Agnes Medical Center where he previously served as Chief, Division of Neurology. Previously, Dr. Bhatia was the Vice Chief, Department of Medicine at Rideout Memorial Hospital. Since 2003, Dr. Bhatia has completed more than 100 clinical trials and has published numerous research papers. He completed his MBBS from Punjab, India and received his Doctor of Medicine from the Albert Einstein College of Medicine. He completed his Neurology Specialty Residency from The State University of New York at Buffalo. “At the Neuropain Medical Center, we pride ourselves on compassionate care by providing clinical trial access for patients to…

San Francisco, Calif., March 15, 2022 – Adaptive Research Inc., an integrated clinical trial site organization with a unique purpose to democratize clinical trials by integrating community physicians into the clinical trial process, today announced that American Molecular Imaging has joined the Adaptive Research network to generate greater access to clinical trials and provide a path to market for groundbreaking medical products.Pharmaceutical companies and clinical research organizations (CROs) on the Adaptive Research network will be able to engage AMI partner imaging locations, enabling these sponsors to select study sites with eligible patients for investigative trials, and to pursue answers to clinical questions with de-identified patient data in the United States. With preferred access to nearly 500 specialty trained radiologists, AMI brings a level of imaging expertise that is unmatched by most radiology groups.“AMI is a key element of our strategy to improve access to clinical trials for patients in need of innovative therapies,” said Deepak Behera, MD, President and Chief Executive Officer of Adaptive Research. “This relationship between Adaptive Research and AMI represents a great example of innovation in the healthcare sector. Our collaboration will increase opportunities for domestic and global pharmaceutical and biotech companies to conduct clinical trials with improved efficiency, as well as improve the local research capabilities and contributions of our general practitioners.”Jaideep S. Sohi, MD, President and Founder, American Molecular Imaging, added, “Our reputation and success are attributed to our patient centric approach focused on customer response, access to radiologists, and fast report turnaround by highly trained and experienced subspecialty radiologists. We are excited to partner with Adaptive Research to broaden our service offering with access to future clinical trials.”About American Molecular Imaging Established in 2012, American Molecular Imaging (AMI) is a physician owned and managed full-line provider of specialized professional radiology interpretation services. At AMI, the foundational goal…

San Francisco, CA, March 14, 2022 – Adaptive Research, an integrated clinical trial site organization with a unique purpose to democratize clinical trials by integrating community physicians into the clinical trial process, announced today the addition of Christine Wong, MD as Director, External Affairs; and Claude Nguyen, MD as Director, Clinical Informatics to the Company’s operations teams.“We are pleased to welcome Drs. Wong and Nguyen to our team as their combined healthcare, clinical trial, and technology expertise will expand our capabilities and position Adaptive Research for significant growth this year,” said Deepak Behera, MD, President & Chief Executive Officer. “In his career, Claude has worked to expand telemedicine to high-need rural areas in the most cost-effective manner possible while preserving high-quality care. Christine’s telemedicine experience along with her ability to foster collaboration across disciplines and geographies will expand our sponsor and physician network.”Dr. Behera, concluded, “In 2021, we increased the number of physicians in our network to over 350,000 patient lives in order to help life science companies tap into a larger, undiluted patient pool from community clinics for their clinical trials. We look forward to the contribution from these experienced professionals as we bridge the divide between technology and healthcare and carry forward our momentum into 2022.”Biographies:Christine Wong, MDConsultant Director, External AffairsDr. Wong is a triple board-certified neurologist (Neurology, Vascular Neurology, Neurocritical care) with over 12 years of clinical, quality, and research experience. She is a founding physician partner of Bay Area Neurospecialists Group, which partners with AHMC Seton Medical Center and at Kentfield Rehabilitation Hospital, to provide exceptional care individuals with brain injury. Previously, Dr. Wong was Attending Physician, Vascular Neurology and Neurocritical Care at Sutter Health California Pacific Medical Center (CPMC) for 9 years and served as Co-Chair of Neurosciences Quality Improvement Committee for 7 years. In this role, Dr. Wong’s keen collaborative skills fostered teamwork across disciplines…

San Francisco, Ca., March 8, 2022 – Adaptive Research, an integrated clinical trial site organization with a unique purpose to democratize clinical trials by integrating community physicians into the clinical trial process, and UBERDOC, the leading direct-to-consumer digital healthcare platform, announced today a collaboration to expand clinical trial access to the physicians and clinical trial sites in the UBERDOC network.With this collaboration Adaptive Research will be provided access to the UBERDOC physicians who are qualified to be clinical trial investigators. Adaptive Research will also have access to the UBERDOC clinics, hospitals, and other similar institutions which have the facilities and staff necessary to run a clinical trial.In turn, UBERDOC will be able to offer Adaptive Research’s clinical trial opportunities to the over 3,000 board-certified physicians and specialists in their network. Adaptive Research offers pharmaceutical companies and clinical research organizations (CROs) a wide range of solutions to improve their clinical trial recruitment, and these companies will now have patient-access through the UBERDOC physician network.“We are excited to partner with UBERDOC to expand our network of physicians, clinics and hospitals,” said Deepak Behera, MD, President & Chief Executive Officer of Adaptive Research. “UBERDOC’s mission to decentralize the healthcare treatment landscape perfectly synergizes with our goal to bring clinical trials to the broader community. We look forward to working together to generate greater access to clinical trials and provide a path to market for groundbreaking medical products.”Paula Muto, MD, FACS, CEO and founder of UBERDOC, added, “As the leading direct-to-consumer digital healthcare platform, we are committed to connecting physicians and patients with the care they need. This partnership with Adaptive Research will alert our physician network of certain clinical trials and give them the support to participate in the trial. This is another way UBERDOC is changing the healthcare status quo by meeting patients…

SAN FRANCISCO, March 16, 2021 (GLOBE NEWSWIRE) -- Adaptive Research Inc. (the “Company”), a healthcare ecosystem that enables community physicians to participate in clinical trials, thereby improving in-need patient access to innovative investigational agents or technologies under development while expanding access to a larger eligible patient pool for biotechnology and pharmaceutical Sponsors, today announced that Mark Tsuchiyose, MD and Dhira Khosla, DO have joined the executive team as Vice President, Clinical Affairs and Therapeutic Head, Gastroenterology, and Vice President, Strategic Clinical Partnerships, respectively.Dr. Tsuchiyose will lead the growth and expansion of the Company’s core businesses and identify other leaders in the field to enhance Adaptive Research mission. Dr. Tsuchiyose is a graduate from University of Southern California School of Medicine in 1983. He completed his Internal Medicine residency at Huntington Memorial Hospital in Pasadena, California and a gastroenterology fellowship at LAC/USC Medical Center. During his 25 years of practice, Dr. Tsuchiyose has been an Associate Clinical Professor at the University of California, San Francisco and a Section Chief in the division of Gastroenterology at Seton Medical Center and served as Chairman of Medicine.Dr. Khosla will lead the Company’s clinical strategic partner initiatives with the business development team. Dr. Khosla is an alumnus of the Philadelphia College of Osteopathic Medicine, completing her neurology residency at SUNY and fellowship in Electromyography and Neuromuscular at Stanford University. As a practicing physician, Dr. Khosla founded a private practice and served as a physician consultant and Principal Investigator for several organizations in the San Francisco Bay Area.“As we look towards 2021, I am pleased to announce the appointment of Dr. Tsuchiyose and Dr. Khosla to expand our current capabilities and offering to biotechnology and pharmaceutical Sponsors. Their respective leadership will be crucial to the successful growth of Adaptive Research,” stated Deepak Behera, MD, President and Chief…